Top compounds associated with response to USP17L12


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.6
mRNA PX-12 CTRPv2 pan-cancer AAC -0.013 0.6
mRNA tivozanib CTRPv2 pan-cancer AAC -0.017 0.6
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.014 0.6
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.015 0.6
mRNA GMX-1778 CTRPv2 pan-cancer AAC 0.016 0.6
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.6
mRNA tivantinib CTRPv2 pan-cancer AAC 0.02 0.7
mRNA Bortezomib gCSI pan-cancer AAC 0.017 0.7
mRNA Teniposide CTRPv2 pan-cancer AAC 0.018 0.7
Download CSV